-
Momentum Stocks: Virtusa Corp. (NASDAQ:VRTU), Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), The AES Corporation (NYSE:AES), Zillow Group (NASDAQ:Z), Nordson Corporation (NASDAQ:NDSN)
On Tuesday shares of Virtusa Corp. (NASDAQ:VRTU) closed at $43.87. Company’s sales growth for last 5 years was 18.10% and EPS growth for next 5 years is recorded as 25.00%. Virtusa Corp. (NASDAQ:VRTU) on Monday reported fiscal fourth-quarter profit of $11.6 million. On a per-share basis, the Westborough, Massachusetts-based company said it had net income…
-
Why Making Dramatic Moves: MannKind Corp. (NASDAQ:MNKD), Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Shutterstock (NYSE:SSTK), Zumiez (NASDAQ:ZUMZ), Theravance Inc. (NASDAQ:THRX)
On Monday shares of MannKind Corp. (NASDAQ:MNKD) closed at $3.63. Company’s EPS growth for next 5 years is recorded as 26.80%. MannKind Corporation (NASDAQ:MNKD), announced that it will present at the Bank of America Merrill Lynch 2015 Healthcare Conference on Wednesday, May 13, 2015 at 12:00 pm Pacific Time at the Encore at the Wynn…
-
Eye Catching Stocks: Valero Energy Corporation (NYSE:VLO), Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Tri Pointe Homes Inc (NYSE:TPH), KLA-Tencor Corporation (NASDAQ:KLAC), Chimerix (NASDAQ:CMRX)
On Monday shares of Valero Energy Corporation (NYSE:VLO) closed at $58.27. Company’s sales growth for last 5 years was 15.20% and EPS growth for next 5 years is recorded as 14.15%. On May 6, Valero Energy Corporation (NYSE:VLO) announced that members of company management will attend the UBS Global Oil and Gas Conference on Wednesday,…
-
Why Need to Watch: Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), North Atlantic Drilling Limited (NYSE:NADL), Vectren (NYSE:VVC), Capital Bank Financial (NASDAQ:CBF), Tesla Motors (NASDAQ:TSLA)
On Friday shares of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) closed at $37.23. Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) on 7 May, provided recent corporate highlights and reported its financial results for the first quarter ended March 31, 2015. “During the first quarter we fortified our financial position through an equity offering, raising more than $190 million to support…
-
Eye Catching Stocks: Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Globalstar Inc. (NYSEMKT:GSAT), Morgan Stanley (NYSE:MS), Kellogg Company (NYSE:K), Texas Roadhouse (NASDAQ:TXRH)
On Monday shares of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) closed at $27.82. Zacks restated their buy rating on shares of Alder Biopharmaceuticals (NASDAQ:ALDR) in a research note issued to investors on Friday. The firm currently has a $31.00 price target on the stock. Globalstar Inc. (NYSEMKT:GSAT) in last trading activity decreased -2.32% to close at $2.53.…
-
Trader’s Watch List: Can-Fite BioPharma (NYSEMKT:CANF), American Tower Corporation (NYSE:AMT), Rock-Tenn Company (NYSE:RKT), Curtiss-Wright Corporation (NYSE:CW), Pilgrim’s Pride Corporation (NASDAQ:PPC)
Can-Fite BioPharma Ltd. (NYSEMKT:CANF) in last trading activity advanced 9.77% to close at $2.92. Company weekly performance is 37.74% while its quarterly performance stands at -13.10%. Can-Fite BioPharma Ltd. (NYSEMKT:CANF) is -49.91% away from its 52 week high. Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small…
-
Top News: Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), PTC Therapeutics (NASDAQ:PTCT), Galectin Therapeutics (NASDAQ:GALT), LeapFrog Enterprises Inc. (NYSE:LF), Delta Air Lines (NYSE:DAL)
Alder Biopharmaceuticals (NASDAQ:ALDR) had its price objective raised by Leerink Swann from $24.00 to $31.00 in a research report released on Thursday morning. Leerink Swann currently has an outperform rating on the stock. On Monday shares of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) closed at $26.29. PTC Therapeutics, Inc. (NASDAQ:PTCT) is not only developing a protein restoration…
-
Stocks Gaining Momentum: Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Recro Pharma (NASDAQ:REPH), MiMedx Group (NASDAQ:MDXG), The Boeing Company (NYSE:BA), Verizon Communications (NYSE:VZ)
Alder Biopharmaceuticals Inc (NASDAQ:ALDR) had its price objective raised by Leerink Swann from $24.00 to $31.00 in a research report released on Thursday morning. Leerink Swann currently has an outperform rating on the stock. On Tuesday shares of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) closed at $27.43. Recro Pharma, Inc. (NASDAQ:REPH) announced a definitive agreement under which…
-
Stock Alert: Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Relypsa (NASDAQ:RLYP), CYREN (NASDAQ:CYRN), Cisco Systems (NASDAQ:CSCO), Johnson & Johnson (NYSE:JNJ)
Alder Biopharmaceuticals (NASDAQ:ALDR) had its target price boosted by Leerink Swann from $24.00 to $31.00 in a report issued on Thursday. They currently have an outperform rating on the stock. On Thursday shares of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) closed at $25.69. Relypsa, Inc. (NASDAQ:RLYP) announced that on March 2, 2015, the compensation committee of the…
-
Stocks Buzz: Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Workiva Inc. (NYSE:WK), CH Robinson Worldwide Inc. (NASDAQ:CHRW), Exelon Corporation (NYSE:EXC), Meru Networks (NASDAQ:MERU)
Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), announced that it will report its fourth quarter and full year 2014 financial and operating results after the close of U.S. financial markets on Wednesday, March 4, 2015. On Monday shares of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) closed at $26.11. Workiva Inc. (NYSE: WK) announced that it will report its fourth quarter…